Patents by Inventor Gregory D. Webster

Gregory D. Webster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11944835
    Abstract: In embodiments, a Wearable Cardioverter Defibrillator (WCD) system includes a support structure for the patient to wear, and components that the support structure maintains on the patient's body. The components include a defibrillator, associated electrodes, and so on. The defibrillator can operate in a WCD mode while the patient wears the support structure. The defibrillator can further operate in a different, AED mode, during which time the patient need not wear a portion of the support structure, or even the entire support structure. Sometimes the AED mode is a type of a fully automatic AED mode. Other times the AED mode is a type of a semi-automated AED mode, where an attendant is present to administer the shock; at such times, the patient may not even need to have electrodes attached. This way the patient is more comfortable for a longer time.
    Type: Grant
    Filed: July 16, 2021
    Date of Patent: April 2, 2024
    Assignee: West Affum Holdings DAC
    Inventors: Brian D. Webster, Zoie R. Engman, Phillip D. Foshee, Jr., David P. Finch, Joseph L Sullivan, Gregory T. Kavounas
  • Patent number: 11927110
    Abstract: An apparatus and method relating to a cooling hole of a component of a turbine engine. The cooling hole can extend from an inlet to an outlet to define a connecting passage. The cooling hole can contain a diffusing section. The diffusing section can be defined by an interior surface having variable geometries.
    Type: Grant
    Filed: January 24, 2022
    Date of Patent: March 12, 2024
    Assignee: General Electric Company
    Inventors: Zachary Daniel Webster, Aaron Ezekiel Smith, Gregory Terrence Garay, Kirk D. Gallier
  • Patent number: 8420125
    Abstract: A medical food and/or nutritional supplement for oral administration by mammals includes ?-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10. A preferred method of manufacturing the medical food or nutritional supplement is by separate microencapsulation of one or more of the components followed by encapsulation of the individual components, for oral administration. Other methods of delivery include packaging in impermeable, disposable packets and mixing the formulations with food or a cold liquid.
    Type: Grant
    Filed: April 11, 2011
    Date of Patent: April 16, 2013
    Assignee: Response Scientific, Inc.
    Inventors: Gregory D. Webster, Emmanuel C. Opara
  • Publication number: 20120093940
    Abstract: A medical food and/or nutritional supplement for oral administration by mammals includes ?-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10. A preferred method of manufacturing the medical food or nutritional supplement is by separate microencapsulation of one or more of the components followed by encapsulation of the individual components, for oral administration. Other methods of delivery include packaging in impermeable, disposable packets and mixing the formulations with food or a cold liquid.
    Type: Application
    Filed: April 11, 2011
    Publication date: April 19, 2012
    Applicant: RESPONSE SCIENTIFIC, INC.
    Inventors: Gregory D. Webster, Emmanuel C. Opara
  • Patent number: 7943163
    Abstract: A medical food and/or nutritional supplement for oral administration by mammals includes ?-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10. A preferred method of manufacturing the medical food or nutritional supplement is by separate microencapsulation of one or more of the components followed by encapsulation of the individual components, for oral administration. Other methods of delivery include packaging in impermeable, disposable packets and mixing the formulations with food or a cold liquid.
    Type: Grant
    Filed: August 22, 2007
    Date of Patent: May 17, 2011
    Assignee: Response Scientific, Inc.
    Inventors: Gregory D. Webster, Emmanuel C. Opara
  • Publication number: 20090054513
    Abstract: A combination of constituents for oral administration by women with polycystic ovarian syndrome includes ?-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10. A preferred method of manufacture is by separate microencapsulation of one or more of the components followed by encapsulation of the individual components, for oral administration. Other methods of delivery include packaging in impermeable, disposable packets and mixing the formulations with food or a cold liquid. A combination of constituents for administration by either men or women to encourage increase in brain insulin levels and/or brain insulin receptor functionality also includes ?-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10.
    Type: Application
    Filed: September 14, 2007
    Publication date: February 26, 2009
    Applicant: RESPONSE SCIENTIFIC, INC.
    Inventors: Gregory D. WEBSTER, Emmanuel C. OPARA
  • Publication number: 20090053303
    Abstract: A medical food and/or nutritional supplement for oral administration by mammals includes ?-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10. A preferred method of manufacturing the medical food or nutritional supplement is by separate microencapsulation of one or more of the components followed by encapsulation of the individual components, for oral administration. Other methods of delivery include packaging in impermeable, disposable packets and mixing the formulations with food or a cold liquid.
    Type: Application
    Filed: August 22, 2007
    Publication date: February 26, 2009
    Applicant: RESPONSE SCIENTIFIC, INC.
    Inventors: Gregory D. WEBSTER, Emmanuel C. Opara